Baba Secures $40M Series A Funding For AI-Powered Medicare Navigation
Baba, a care platform, has raised $40M in series A funding to enhance its AI-powered Medicare patient navigation, backed by FirstMark Capital and CVS Health Ventures. This investment aims to improve coordinated care for millions of Americans with complex needs.
Original reporting · fiercehealthcare.com
Original: “Baba nabs $40M series A, backed by FirstMark Capital and CVS Health Ventures, for AI-powered Medicare patient navigation”
Read “Baba nabs $40M series A, backed by FirstMark Capital and CVS Health Ventures, for…” at Fierce Healthcare →
How this was written. Diagnosis Forward wrote this article with a language model from Fierce Healthcare’s reporting (model: @cf/meta/llama-3.3-70b-instruct-fp8-fast); it describes that reporting rather than adding to it. The original, linked above, is the full story.
Key points from Fierce Healthcare’s report
- Baba has raised $40M in series A funding to enhance its AI-powered Medicare patient navigation.
- The company's care platform connects Medicare and Medicaid patients to dedicated care teams and has supported over 10,000 patients.
- Baba plans to use the funding to further its research, expand its reach to more health plans, and accelerate value-based arrangements.
- The company is building an applied research effort for AI solutions involving complex care and has launched a benchmark to measure AI agents' ability to handle patient advocacy tasks.
- Baba's efforts aim to deliver coordinated and accountable care to patients and their families at scale.
Baba, a care platform founded in 2025, has secured $40M in series A funding, according to Fierce Healthcare. The funding round was led by FirstMark Capital, with participation from CVS Health Ventures and Valtruis, as well as returning investors General Catalyst, Genius Ventures, and Ground Up Ventures.
The company's care platform connects Medicare and Medicaid patients to dedicated care teams, including care coordinators and licensed therapists. Baba has partnered with national health plans, government agencies, and other organizations, supporting over 10,000 patients with 100,000 families on its waiting list.
FirstMark Capital co-founder and partner Rick Heitzmann stated that Baba has proven AI can bring coordinated, concierge-level care to Medicare patients and families. Heitzmann views Baba as a key player in the consumerization of healthcare, particularly for rural, older Americans with complex needs.
The U.S. Centers for Medicare and Medicaid Services has selected Baba for the 10-year ACCESS model, which aims to improve care for patients with chronic conditions. Baba plans to use the funding to further its research, expand its reach to more health plans, and accelerate value-based arrangements.
Baba CEO and founder Connor Sweeney noted that the fresh capital will enable the company to scale its care delivery and coordination for people on government-sponsored coverage. The company's primary focus is on deepening its work with payers on value-based arrangements and building a model where it takes on risk.
In addition to its care platform, Baba is also building an applied research effort for AI solutions involving complex care. The company has launched BabaBench, a benchmark that measures the ability of AI agents to handle long-horizon patient advocacy tasks such as paperwork, billing, and insurer calls.
With this funding, Baba aims to deliver coordinated and accountable care to patients and their families at scale. The company's efforts to improve Medicare patient navigation and expand its research capabilities may have a significant impact on the healthcare industry.
Questions and answers
What is Baba's care platform?
Baba's care platform connects Medicare and Medicaid patients to dedicated care teams, including care coordinators and licensed therapists.
How will Baba use the funding?
Baba plans to use the funding to further its research, expand its reach to more health plans, and accelerate value-based arrangements.
What is BabaBench?
BabaBench is a benchmark that measures the ability of AI agents to handle long-horizon patient advocacy tasks such as paperwork, billing, and insurer calls.
